(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202309 | 202209 | % Var | 202309 | 202209 | % Var | 202303 | 202203 | % Var | |
| Sales | 26345.90 | 24614.90 | 7.03 | 48877.60 | 45198.40 | 8.14 | 90545.50 | 88298.10 | 2.55 |
| Other Income | 618.40 | 736.40 | -16.02 | 1265.40 | 1289.50 | -1.87 | 2662.90 | 1998.90 | 33.22 |
| PBIDT | 7164.40 | 4793.20 | 49.47 | 11148.90 | 7179.40 | 55.29 | 16432.40 | 20102.50 | -18.26 |
| Interest | 187.00 | 200.20 | -6.59 | 401.20 | 420.40 | -4.57 | 864.00 | 379.00 | 127.97 |
| PBDT | 6977.40 | 4593.00 | 51.91 | 10747.70 | 6759.00 | 59.01 | 15568.40 | 19723.50 | -21.07 |
| Depreciation | 590.20 | 577.40 | 2.22 | 1171.30 | 1145.50 | 2.25 | 2298.50 | 2189.80 | 4.96 |
| PBT | 6387.20 | 4015.60 | 59.06 | 9576.40 | 5613.50 | 70.60 | 13269.90 | 17533.70 | -24.32 |
| TAX | -77.90 | 508.70 | -115.31 | 396.90 | 705.60 | -43.75 | 1925.20 | 2121.20 | -9.24 |
| Deferred Tax | -1192.70 | -191.10 | 524.12 | -1257.20 | -269.30 | 366.84 | -350.00 | -917.00 | -61.83 |
| PAT | 6465.10 | 3506.90 | 84.35 | 9179.50 | 4907.90 | 87.04 | 11344.70 | 15412.50 | -26.39 |
| Equity | 239.10 | 239.10 | 0.00 | 239.10 | 239.10 | 0.00 | 239.10 | 239.10 | 0.00 |
| PBIDTM(%) | 27.19 | 19.47 | 39.65 | 22.81 | 15.88 | 43.60 | 18.15 | 22.77 | -20.29 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: